Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,

Frontotemporal Dementia After the Bruce Willis Effect: What Neurologists Should Revisit

Frontotemporal Dementia After the Bruce Willis Effect What Neurologists Should Revisit Review Abstract The public disclosure of a frontotemporal dementia diagnosis by Bruce Willis brought unprecedented public attention to a neurodegenerative disorder that has historically remained underrecognized outside specialized neurology and memory clinics. While increased awareness has

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early

Plasma Biomarkers for Neurodegenerative Disease: What Clinicians Need to Know in 2026

Plasma Biomarkers for Neurodegenerative Disease What Clinicians Need to Know in 2026 Review Key Takeaways Plasma biomarkers are rapidly transforming the diagnosis and management of Alzheimer’s disease and related dementias, representing one of the most notable advances in neurodegenerative medicine in recent decades. Historically, the definitive assessment of Alzheimer’s pathology has

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient